Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by Jimpro63on Mar 29, 2020 4:13pm

88 Views

Post# 30858004

RE:Please do some Due Diligence before making dumb posts lol

Bacterial and viral infections have many things in common. Both types of infections are caused by microbes -- bacteria and viruses, respectively -- and spread by things such as:

Coughing and sneezing.
Contact with infected people, especially through kissing and sex.
Contact with contaminated surfaces, food, and water.
Contact with infected creatures, including pets, livestock, and insects such as fleas and ticks.

We haven't even talked about Vaxil Biotechnology 's Cancer research yet .